Pricing Log in Create free account
Reset Show values

Graham Defensive Investor

Large, sound companies with an unbroken dividend and earnings growth, at a modest price.

Open in screener How it works

Dividend Growth

Reliable payers with room to keep paying: a decade without a cut, a covered dividend, growing earnings.

Open in screener How it works

High Insider Buying

Companies where three or more insiders bought shares in the open market in the last three months.

Open in screener How it works

Piotroski High Score

Cheap companies whose finances are improving on eight or nine of Piotroski's nine tests.

Open in screener How it works

TTM trailing twelve months Q latest quarter A latest fiscal year D daily, from the latest close

Showing the 10 largest of 149 matches.
1 filter active
median
thirds
Table Snapshots

  1. Abbott Laboratories

    ABT Healthcare · Medical Devices · US

    $113.42 −8.93% 1Y
    Low $81.97 High $132.03

    Abbott Laboratories is a healthcare-products company headquartered in North Chicago and led by Chief Executive Officer Robert Ford. It discovers, develops, manufactures and sells products across four businesses: Medical Devices, Diagnostic Products, Nutritional Products and Established Pharmaceutical Products.

    Market cap $196.6B
    Revenue growth (Q) +14.5%
    EPS growth (Q) −43.6%
    FCF growth (Q) +28.9%
    Revenue growth (next yr) +12.7%
    Net margin 9.75%
    ROE 0.00%
    P/E 42.3×
    Forward P/E 35.1×
    P/FCF 25.2×
    Dividend yield 2.22%
    Insider ownership 1.17%
    Insider buys / sells (12M) $4.4M $47.5M
    Reported FY2022 FY2023 FY2024 FY2025 TTM
    Revenue $43.7B $40.1B $42.0B $44.3B $48.2B
    EPS $3.91 $3.26 $7.64 $3.72 $2.68
    Free cash flow $7.8B $5.1B $6.4B $7.4B $6.8B
    Net debt $6.6B $7.4B $6.2B $4.0B $26.9B

  2. Medtronic PLC

    MDT Healthcare · Medical Devices · IE

    $104.51 +15.6% 1Y
    Low $73.31 High $106.33

    Medtronic is a healthcare technology company headquartered in Galway, Ireland. Founded in 1949, it develops, manufactures, distributes and sells device-based medical therapies and related services.

    Market cap $134.1B
    Revenue growth (Q) +13.7%
    EPS growth (Q) +40.7%
    FCF growth (Q) +120.9%
    Revenue growth (next yr) +7.17%
    Net margin 13.9%
    ROE 10.6%
    P/E 25.6×
    Forward P/E 20.8×
    P/FCF 21.8×
    Dividend yield 2.74%
    Insider ownership 0.00%
    Insider buys / sells (12M) — $14.7M
    Reported FY2023 FY2024 FY2025 FY2026 TTM
    Revenue $31.2B $32.4B $33.5B $36.4B $37.5B
    EPS $2.82 $2.76 $3.61 $3.73 $4.06
    Free cash flow $4.6B $5.2B $5.2B $5.4B $6.1B
    Net debt $16.4B $17.0B $19.6B $18.7B $19.3B

  3. Stryker Corporation

    SYK Healthcare · Medical Devices · US

    $333.88 −6.65% 1Y
    Low $267.00 High $389.33

    Stryker is a medical technology company that sells equipment, implants and other products used in hospitals and other healthcare facilities. Its businesses cover medical and surgical care, treatments for vascular and neurological conditions, and orthopaedics.

    Market cap $127.6B
    Revenue growth (Q) +7.64%
    EPS growth (Q) −11.7%
    FCF growth (Q) −19.4%
    Revenue growth (next yr) +6.77%
    Net margin 13.8%
    ROE 16.0%
    P/E 35.3×
    Forward P/E 24.6×
    P/FCF 28.9×
    Dividend yield 1.05%
    Insider ownership 6.25%
    Insider buys / sells (12M) — $401.5M
    Reported FY2022 FY2023 FY2024 FY2025 TTM
    Revenue $18.4B $20.5B $22.6B $25.1B $26.3B
    EPS $6.17 $8.25 $7.76 $8.40 $9.39
    Free cash flow $2.0B $3.1B $3.5B $4.3B $4.4B
    Net debt $11.1B $9.9B $9.1B $11.8B $11.7B

  4. Boston Scientific Corporation

    BSX Healthcare · Medical Devices · US

    $44.36 −55.2% 1Y
    Low $39.57 High $105.65

    Boston Scientific develops, manufactures and markets medical devices used by physicians and other medical professionals. Its products help diagnose and treat conditions affecting the heart and blood vessels, digestive and urinary systems, and nervous system, as well as some cancers.

    Market cap $64.7B
    Revenue growth (Q) +1.44%
    EPS growth (Q) −21.6%
    FCF growth (Q) −25.3%
    Revenue growth (next yr) +4.44%
    Net margin 16.6%
    ROE 14.2%
    P/E 18.7×
    Forward P/E 17.0×
    P/FCF 19.3×
    Dividend yield —
    Insider ownership 0.60%
    Insider buys / sells (12M) $10.0M $18.1M
    Reported FY2022 FY2023 FY2024 FY2025 TTM
    Revenue $12.7B $14.2B $16.7B $20.1B $21.1B
    EPS $0.45 $1.07 $1.25 $1.94 $2.36
    Free cash flow $950.0M $1.8B $2.6B $3.7B $3.3B
    Net debt $8.0B $8.2B $10.3B $9.5B $11.3B

  5. Edwards Lifesciences Corporation

    EW Healthcare · Medical Devices · US

    $100.35 +21.1% 1Y
    Low $74.66 High $104.17

    Edwards Lifesciences makes medical devices for structural heart disease, with a focus on repairing or replacing heart valves. A faulty valve can disrupt the heart’s function or blood flow.

    Market cap $58.1B
    Revenue growth (Q) +10.5%
    EPS growth (Q) +6.00%
    FCF growth (Q) −1.84%
    Revenue growth (next yr) +11.4%
    Net margin 15.3%
    ROE 9.65%
    P/E 56.7×
    Forward P/E 36.5×
    P/FCF 41.5×
    Dividend yield —
    Insider ownership 1.20%
    Insider buys / sells (12M) — $27.7M
    Reported FY2022 FY2023 FY2024 FY2025 TTM
    Revenue $4.5B $5.0B $5.4B $6.1B $6.7B
    EPS $2.44 $2.30 $6.97 $1.83 $1.76
    Free cash flow $953.4M $629.5M $259.9M $1.3B $1.4B
    Net debt −$619.0M −$1.0B −$3.4B −$3.6B −$4.0B